Terazosin Hydrochloride



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 21.7%
Benign Prostatic Hyperplasia 17.4%
Drug Use For Unknown Indication 17.4%
Completed Suicide 13.0%
Urinary Retention 13.0%
Blood Pressure Increased 4.3%
Hypertension 4.3%
Prostate Examination Abnormal 4.3%
Urinary Tract Disorder 4.3%
Loss Of Consciousness 23.1%
Ventricular Extrasystoles 15.4%
Agitation 7.7%
Completed Suicide 7.7%
Dysuria 7.7%
Gastrooesophageal Reflux Disease 7.7%
Nocturia 7.7%
Rash 7.7%
Syncope 7.7%
Urinary Tract Disorder 7.7%
Secondary
Drug Use For Unknown Indication 23.0%
Product Used For Unknown Indication 21.6%
Hypertension 17.6%
Type 2 Diabetes Mellitus 5.4%
Blood Pressure 4.1%
Cardiovascular Event Prophylaxis 4.1%
Hyperuricaemia 4.1%
Hypothyroidism 4.1%
Prophylaxis 4.1%
Renal Failure Chronic 4.1%
Acute Coronary Syndrome 2.7%
Anxiety 1.4%
Benign Prostatic Hyperplasia 1.4%
Blood Pressure Increased 1.4%
Smoking Cessation Therapy 1.4%
Nephritis Interstitial 10.0%
Presyncope 10.0%
Priapism 10.0%
Syncope 10.0%
Wheezing 10.0%
Cardiac Arrest 5.0%
Disorientation 5.0%
Dizziness 5.0%
Dysuria 5.0%
Hyperkalaemia 5.0%
Orthostatic Hypotension 5.0%
Pneumonia 5.0%
Rash 5.0%
Systemic Lupus Erythematosus 5.0%
Throat Tightness 5.0%
Concomitant
Product Used For Unknown Indication 24.5%
Drug Use For Unknown Indication 21.8%
Hypertension 11.4%
Blood Pressure 8.8%
Diabetes Mellitus 5.1%
Prophylaxis 3.0%
Rheumatoid Arthritis 2.5%
Multiple Myeloma 2.4%
Benign Prostatic Hyperplasia 2.2%
Pain 2.1%
Hyperlipidaemia 1.9%
Swelling 1.9%
Blood Cholesterol 1.8%
Arthritis 1.7%
Blood Cholesterol Increased 1.7%
Gastrooesophageal Reflux Disease 1.7%
Back Pain 1.5%
Cardiac Disorder 1.5%
Depression 1.3%
Osteoporosis 1.3%
Wrist Fracture 11.3%
Vomiting 10.1%
Rhabdomyolysis 8.2%
Flushing 7.5%
Wound Drainage 6.9%
Urinary Retention 6.3%
Drug Ineffective 5.7%
Wrong Technique In Drug Usage Process 5.7%
Unresponsive To Stimuli 5.0%
Urinary Tract Infection 4.4%
Diarrhoea 3.1%
Tooth Repair 3.1%
Type 2 Diabetes Mellitus 3.1%
Vision Blurred 3.1%
Weight Decreased 3.1%
Wound Dehiscence 3.1%
Blood Glucose Increased 2.5%
Burning Sensation 2.5%
Chest Discomfort 2.5%
Dyspnoea 2.5%